News – Page 590
-
News
Chemical industry hopes to avoid EU permit payments
Chemical companies are lobbying hard to avoid having to buy permits to emit carbon dioxide under the third phase of the EU emissions trading scheme (ETS)
-
Business
Business roundup: December 2008
GSK snaps up hepatitis expert In a bid to strengthen its position in the race to develop new hepatitis therapies, UK pharma giant GlaxoSmithKline (GSK) has agreed to buy Genelabs Technologies in a deal worth $57 million (£35 million). Source: © ISM / Science Photo Library Liver cells ...
-
News
Virus revealed by flipping lipid
Drug flags up virus-infected cells for destruction by the body's own immune system
-
News
Silicon for better batteries
Using silicon in lithium ion batteries could make devices run seven times longer
-
News
New UK drug pricing system agreed
Deal cuts pharma profits, boosts generics, and may lead to more approvals for new medicines
-
News
ERC concludes first phase of advanced grants
Half a billion euros dished out to well-established scientists
-
News
BASF closes 80 plants as demand slumps
Temporary shutdowns and production cuts represent 25 per cent of company's total capacity
-
News
Colourful future for nanowires
Fine tuning the crystal structures of nanowires could boost the efficiency of LEDs and other electronic components
-
News
Debate still heated on China's fusion plans
Scientists question country's involvement in Iter, the international fusion project
-
News
Catalyst flexes for extra control
Flexibility is key for a new type of olefin metathesis catalyst
-
News
Traditional Chinese medicine firm struggles for approval
China's drug regulator asked to reconsider decision to reject anti-HIV herbal drug
-
News
Reactions studied by stop motion
Ultra-fast spectroscopy tracks changes during polyatomic reactions
-
News
Microscope reveals catalyst secrets
New X-ray spectroscopy 'nanoreactor' watches catalysts in action